search button
Open Access

β‑hydroxybutyrate does not alter the effects of glucose deprivation on breast cancer cells

  • Authors:
    • Rylee Maldonado
    • Chloe Adrienna Talana
    • Cassaundra Song
    • Alyssa Dixon
    • Kahealani Uehara
    • Michael Weichhaus

  • View Affiliations

  • Published online on: November 23, 2020     https://doi.org/10.3892/ol.2020.12326
  • Article Number: 65

  • Copyright: © Maldonado et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ketogenic diets have the potential to lower glucose availability to cancer cells. However, the effect that the resulting increase in ketone bodies has on cancer cells is not fully understood. The present study explored the effect of β‑hydroxybutyrate (BHB) on glucose‑deprived MCF‑7 and T47D breast cancer cells. Cell proliferation was decreased in response to lower glucose conditions, which could not be rescued consistently by 10 or 25 mM BHB supplementation. In addition, gene expression levels were altered when cells were glucose deprived. Reducing glucose availability of cancer cells to 225 mg/l for 4 days significantly decreased the expression of 113 genes and increased the expression of 100 genes in MCF‑7 breast cancer cells, and significantly decreased the expression of 425 genes and increased the expression of 447 genes in T47D breast cancer cells. Pathway enrichment analysis demonstrated that glucose deprivation decreased activity of the Hippo‑Yap cell signaling pathway in MCF‑7 breast cancer cells, whereas it increased the expression of genes in the NRF2‑pathaway and genes regulating ferroptosis in T47D breast cancer cells. Treatment of glucose‑deprived cells with 10 or 25 mM BHB significantly changed the expression of 14 genes in MCF‑7 breast cancer cells and 40 genes in T47D breast cancer cells. No significant pathway enrichment was detected when glucose‑deprived cells were treated with BHB. Both cell lines expressed the enzymes (OXCT1/2, BDH1 and ACAT1/2) responsible for metabolizing BHB to acetyl‑CoA, yet expression of these enzymes was not altered by either glucose deprivation or BHB treatment. In the publicly available The Cancer Genome Atlas (TCGA), increased expression of ketone body‑catabolizing enzymes was observed in various types of cancer based on mRNA expression z‑scores. Increased expression of BDH1 and ACAT1 significantly decreased overall survival of patients with breast cancer in TCGA studies, while decreased OXCT1 expression non‑significantly decreased overall survival. In conclusion, neither MCF‑7 nor T47D breast cancer cells were affected by BHB during glucose deprivation; however, screening of tumors for activation of ketone body‑metabolizing enzymes may be able to identify patients that will benefit from ketogenic diet interventions.
View Figures
View References

Related Articles

Journal Cover

January-2021
Volume 21 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.5
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 5.7
  • CiteScore Rank: Q2: #139/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.574
  • SCImago Journal Rank (SJR): 0.644
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Maldonado R, Talana CA, Song C, Dixon A, Uehara K and Weichhaus M: β‑hydroxybutyrate does not alter the effects of glucose deprivation on breast cancer cells. Oncol Lett 21: 65, 2021.
APA
Maldonado, R., Talana, C.A., Song, C., Dixon, A., Uehara, K., & Weichhaus, M. (2021). β‑hydroxybutyrate does not alter the effects of glucose deprivation on breast cancer cells. Oncology Letters, 21, 65. https://doi.org/10.3892/ol.2020.12326
MLA
Maldonado, R., Talana, C. A., Song, C., Dixon, A., Uehara, K., Weichhaus, M."β‑hydroxybutyrate does not alter the effects of glucose deprivation on breast cancer cells". Oncology Letters 21.1 (2021): 65.
Chicago
Maldonado, R., Talana, C. A., Song, C., Dixon, A., Uehara, K., Weichhaus, M."β‑hydroxybutyrate does not alter the effects of glucose deprivation on breast cancer cells". Oncology Letters 21, no. 1 (2021): 65. https://doi.org/10.3892/ol.2020.12326